Biogen Inc.

Biogen Inc. (BIIB) — Form 10-Q: Quarterly report

10-QBIIBFiled Oct 28, 2026, 6:23 AM ET· Period Sep 30, 2026

AI-generated summary

Biogen Inc. filed its quarterly report for the period ended September 30, 2026. The filing provides a comprehensive discussion of financial condition, market risks, legal proceedings, and internal controls. No share repurchases were made during the third quarter of 2026.

View original filing on SEC.gov

Key facts

Document: 10-Q

More BIIB filings

8-K
Current report
Filed Oct 28, 2026
4
Insider transaction
Filed Oct 5, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.